Our previous study in chronic myeloid leukemia (CML) found that Tim‐3 was highly expressed in a subset of CD34+CD38+CD123high progenitors and could be a simple and less addressed surface marker of CML LSC.12 This evidence concerns the gene HAVCR2 and chronic myelogenous leukemia, BCR-ABL1 positive.